American joint committee on cancer staging of uveal melanoma.

Authors

Phoebe L Mellen, Department of Ocular Oncology, Wills Eye Institute, Thomas Jefferson UniversityFollow
Spenser J Morton, Department of Ocular Oncology, Wills Eye Institute, Thomas Jefferson UniversityFollow
Carol L Shields, Department of Ocular Oncology, Wills Eye Institute, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

5-1-2013

Comments

This article has been peer reviewed. It was published in: Oman journal of ophthalmology.
Volume 6, Issue 2, 2013, Pages 116-118.
The published version is available at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779409/. DOI: 10.4103/0974-620X.116652
Copyright © 2013 Mellen PL, et al.

Abstract

In January 2010, the American Joint Committee on Cancer (AJCC) updated its staging criteria for uveal melanoma. Here, we discuss the staging classifications and evaluate an interesting case to demonstrate. The development of a uniform means of staging cancer, such as defined by the AJCC, is critical for information sharing among the research community.

Recommended Citation

Mellen, Phoebe L; Morton, Spenser J; and Shields, Carol L, "American joint committee on cancer staging of uveal melanoma." (2013). Wills Eye Hospital Papers. Paper 41.
https://jdc.jefferson.edu/willsfp/41

PubMed ID

24082672